Introduction
The central carbon metabolism (CCM) supplies bioprecursors and energy in most living cells including the gram negative bacterium Escherichia coli. The interconnected pathways composing the CCM include glycolysis, gluconeogenesis, the tricarboxylic acid cycle (TCA cycle) and pentose phosphate pathways (PPP) (Holms, 1996) . Carbon and energy fluxes in the CCM are highly regulated in a complex, multilevel network with many control loops (Heinemann and Sauer, 2010; Kotte et al., 2010; Enjalbert et al., 2011; Shimizu, 2014) . In contrast to transcriptional and post-translational controls, the occurrence of post-transcriptional control (i.e., regulation of RNA stability and translation) remains poorly characterized in E. coli.
A post-transcriptional regulatory system considered to control various metabolic pathways is carbon storage regulator (CSR). The main component of the CSR system is the essential global regulator CsrA. This protein prevents the translation of target mRNA by binding near the ribosome binding site, thereby inhibiting translation and/or facilitating mRNA decay (Timmermans and Van Melderen, 2010; Seyll and Van Melderen, 2013; Duss et al., 2014) . CsrA can also mediate gene activation by stabilizing target transcripts, but the demonstration of such mechanisms is still rare in the literature (Wei et al., 2001; Yakhnin et al., 2013) . The post-transcriptional regulatory system CSR has been directly demonstrated to be involved in the regulation of a wide range of physiological processes including biofilm formation, peptide uptake, motility, virulence and carbohydrate storage (Timmermans and Van Melderen, 2010; Romeo et al., 2013) .
The CSR system is also supposed to regulate CCM pathways. Several works (performed with different approaches, conditions and strains) have reported that CSR system is a potential regulator of a dozen targets in the CCM (positive effect for Pgi, PfkA, TpiA, Eno, PykF and Acs, and negative control for Pgm, GlgA, GlgB, GlgC, PfkB, Fbp, Pck and Pps) (Romeo et al., 1993; Sabnis et al., 1995; Yang et al., 1996; Wei et al., 2000; McKee et al., 2012) . Moreover, the CSR system is regarded as essential for growth on glycolytic media (Altier et al., 2000; Timmermans and Van Melderen, 2009 ). This is a surprising property, given that other global or pleiotropic regulators such as RelA/SpoT, Crp-cAMP or RpoS are not essential (Adams and McLean, 1999; Nguyen et al., 2011; Sabourin and Beckwith, 1975) . The origins of this essentiality are unclear (Timmermans and Van Melderen, 2009; Revelles et al., 2013) . Taking as a whole, several clues supposed that the CCM is regulated by the CSR system but the physiological consequences of CSR-mediated regulations on the bacterial metabolism have not been characterized yet. It remains to be determined which of the multiple targets of CSR in the CCM are important for the cell physiology and if CSR could contribute in any extent to the coordination of these targets.
Here, we assessed the influence of CsrA on the CCM through a multilevel investigation (including growth parameters, gene expression levels, metabolite pools, enzyme activities and fluxes). These investigations were performed in a mutant strain with an attenuated CsrA protein and its isogenic wild type. The use of these datasets combined with modelling and experimental confirmations enabled us to demonstrate the crucial role of the CSR system in the control of the phosphofructokinase expression and its consequences on the upper part of the glycolysis. This work highlights for the first time the major role of post-transcriptional regulation in the correct tuning of the central carbon metabolism.
Results
The csrA51 strain displayed a growth defect associated with a low glucose uptake rate
To assess the influence of CsrA on the CCM, the behavior of strain E. coli MG1655 on glucose in various media was compared to its isogenic csrA51 mutant strain. This strain is carrying an attenuated but viable variant of CsrA (deletion of the last 10 amino acids of the protein; see Experimental procedures). The construction and its resulting phenotypes on motility, biofilm production and glycogen content have been validated elsewhere (Esquerr e et al., submitted) . As expected (Romeo et al., 1993; Sabnis et al., 1995) , we confirmed that the mutation did not significantly affect the growth rate on rich LB medium in an Erlenmeyer flask (maximum growth rates l 5 1.26 6 0.07 h 21 for the csrA51 strain and 1.38 6 0.07 h 21 for the wild type; Table 1 ). Due to the essentiality of csrA for growth on glucose, this carbon source is expected to negatively affect growth of the csrA51 strain. Addition of glucose to the Lysogeny broth (LB) reduced the maximum growth rate of the csrA51 strain to l 5 0.96 6 0.18 h 21 while it increased the wildtype (WT) maximum growth rate to l 5 1.52 6 0.04 h 21 . The negative influence of glucose on the mutant was also assessed by growing both strains on M9 minimal medium with glucose as the sole carbon source. The cultures were performed in well-controlled conditions in bioreactors (controlled oxygenation, temperature and pH; see Experimental procedures). In these conditions, the csrA51 strain grew significantly more slowly than the WT strain with a maximum growth rate reduced to 54% of that of the WT strain (Table 1) . Likewise, the specific consumption rate of glucose was 37% lower in the csrA51 strain than in the Table 1 . Macrophenotypic parameters for wild-type and csrA51 strains during exponential growth. Parameter values (mean 6 SD) are issued from three independent replicates as described in the Experimental procedures. Maximal growth rates, glucose-specific uptake rates, acetate and biomass yield, glycogen content and specific CO 2 production rates have been calculated during the exponential phase.
Medium
Parameter wild type. In both strains, acetate accumulated throughout the exponential phase but in the csrA51 strain, acetate accumulation was reduced to 6% of that observed in the WT strain (Table 1) . This confirms a previous result obtained in a strain with a reduced CsrA availability obtained by overexpressing csrB, a gene encoding a small RNA able to sequestrate csrA (McKee et al., 2012) . Aside from acetate, no fermentation products accumulated in the mutant, as demonstrated by total organic carbon assays (supporting information S1). As expected from the literature (Yang et al., 1996) , glycogen content is 6.8 times higher in the csrA51 strain than in the wild type. CO 2 was also quantified in the gas phase where the production of CO 2 was demonstrated to be lower in the csrA51 strain than in the WT (Table 1) . Finally, the biomass yield from glucose consumption is similar in both the WT and csrA51 strains. This suggests that the growth defect of the csrA51 strain on glucose is not related to a decrease in the efficiency of biomass synthesis but rather to a reduction in the rate of glucose consumption.
CSR impact on CCM fluxes
The reduction of growth rate and glucose uptake rate in the csrA51 strain should provoke a uniform decrease of the fluxes in the CCM. Beside this quantitative change, the csrA51 mutation could also affect the flux partition through the local control of CSR-putative targets. Therefore, we determined the intracellular distribution of fluxes in the wild-type and csrA51 strains by integrating uptake and secretion rates, as well as the biomass and glycogen production rates into a genome-scale reconstruction of the E. coli genome (Feist et al., 2007) . Since the glycogen content was found stable during the whole exponential phase of both strains (data not shown), the glycogen production rate was set up as a linear function of the growth rate. The biomass reaction was set to the measured growth rate. Constraints related to thermodynamics and to the composition of the growth medium were imposed (see Experimental procedures and supporting information S2 and S3). Metabolic flux analysis was performed, using as objective the minimization of the discrepancies between the predicted and measured fluxes (Antoniewicz, 2015) . We further analysed the optimal solutions by flux variability analysis (Mahadevan and Schilling, 2003) , to determine the minimum and maximum flux values satisfying the constraints and consistent with the measurements. This allowed restricting the possible values of intracellular fluxes to very tight intervals ( Fig. 1 and Supporting Information S2 for details). In the csrA51 strain, fluxes globally decreased in the CCM consistently with the decrease of glucose uptake rate. However, this decrease is not uniform with a higher diminution for the glycolytic flux compared to the TCA fluxes. Interestingly, the observed flux variations are constant inside both of these pathways. The strongest decrease was observed for the glucose-6-phosphate dehydrogenase flux (i.e., the first step towards the pentose phosphate pathway). Unlike in the CCM, higher fluxes were calculated in the glycogen synthesis pathway in the csrA51 strain. We conclude that the phenotypic differences observed between both strains in Table 1 are associated with important flux reshaping.
CSR impact on CCM gene expression
The phenotypes and fluxes are deeply impacted in the csrA51 strain. This is very likely to result from differential gene expression in the csrA51 mutant. There is ample information about the effect of CSR on the CCM gene expression in the literature. However, this information is fractionated (and sometimes contradictory) as it is issued from works performed with a variety of measurement approaches, genetic backgrounds and growth conditions. We therefore re-investigated, for consistency, the impact of CSR on the gene expression levels during the exponential growth on M9 supplemented with glucose ( Fig. 2 ). Higher expression of the glgC and pgm genes (both involved in glycogen biosynthesis) was found in the csrA51 strain consistent with previous works (Romeo et al., 1993; Liu et al., 1995; Sabnis et al., 1995) . All the glycolytic genes were significantly less expressed in the mutant (ptsG, pgi, pfkA, tpi, eno and pyk), while gluconeogenic genes (fbp, pps) presented nonsignificant variations. For the genes related to the TCA, strong up-regulation was detected for pckA while low or nonsignificant changes were observed for icd, sucA, sdh, mdh, aceA and aceB. In the acetate metabolic pathways, acs gene expression was upregulated in the csrA51 strain, while the expression of pta and ackA did not change significantly. Since these expression ratios have been obtained in the same experimental conditions, it is now possible to identify which genes are the most impacted by CsrA mutation. The highest impacts were observed for glgC and pgm (glycogen pathways), pckA (TCA pathways), acs (acetate metabolism) and pfkA (glycolysis pathway). To conclude, in the csrA51 strain, the uniform down-regulation of glycolytic genes as well as the strong up-regulation of the genes involved in glycogen synthesis is consistent with the flux distribution described above.
Fig. 2.
Comparison of mRNA contents in the CCM between the wild type and the csrA51 strains. mRNA data are issued from three independent replicates for the csrA51 strain and its isogenic wild type (mean 6 SD). The displayed values correspond to the log2 of the ratio of the csrA51 strain to its isogenic wild type (with propagation of uncertainty). The asterisk represents significant ratio (P value <5% determined by t-test). The colour code matches the entity pathway (blue for the glycogen synthesis pathway, orange for the glycolysis pathway and gluconeogenesis pathways, pink for the pentose phosphate pathway, green for the TCA cycle and light brown for acetate metabolism pathway 
CSR impact on CCM enzymatic levels and metabolite pools
Besides its control on gene expression, CsrA is also known to modify translation level by interfering with the ribosome fixation. We therefore investigated if enzymatic levels follow differential gene expressions in the CCM (Fig. 3 ). As for their transcripts, the amount of glycogenic enzymes GlgC and Pgm was increased in the csrA51 mutant while the glycolytic enzyme levels decreased. Abundances of the enzymes related to the TCA (AceA, AceB and PckA) were significantly enhanced in the CsrA mutant. Therefore, most of the observed enzyme level modifications were in good agreement with gene expression results. We then investigated if the observed impacts on protein level could indirectly result from the growth rate reduction of the csrA51 strain in regard to the wild-type strain. This was answered by using the data set from Esquerr e et al. (2014) and by comparing enzymatic levels in the wild type in chemostatic growth at 0.3 h 21 (i.e., the csrA51 growth rate) to the wild-type maximal growth rate on M9 glucose (0.6 h 21 ). This revealed that decreasing the growth rate in the wild type increased levels of enzymes related to the TCA (AceA, AceB and Pck) like previously observed in the mutant. In contrast, glycogenic and glycolytic levels are mostly not affected by the growth rate reduction.
The huge impact of CsrA on the CCM is expected to modify the metabolite pools. We therefore investigated the concentrations of metabolites in both the csrA51 mutant and the wild-type strains (Fig. 4 ). Glycogen content and the concentration of its precursor (ADP-glucose) were, respectively, 7 and 5 times higher in the csrA51 strain. Likewise, metabolite pools from the upper glycolysis (G6P and F6P) were 2.5 times higher in the csrA51 cells. Metabolite pools of the pentose phosphate pathway (6PG, S7P and R5P) increased from 1.5 to 7 times in the csrA51 strain. In contrast, no significant difference was found in metabolite pools downstream of F6P in the glycolytic pathway (FBP, 2,3PG and PEP) or in the TCA, except for the fumarate pool, which was significantly reduced in the csrA51 strain.
Again, we investigated if the differential metabolite concentrations could results from the reduced growth rate in the csrA51 strain ( Fig. 4 ). This revealed that the lower metabolite pools observed in the TCA cycle of the mutant could be explained by the growth reduction while the over-accumulation of metabolites in the upper glycolysis was more directly related to the mutation. These results strengthened that the core function of CSR in the CCM is the regulation of upper glycolysis activities to regulate the metabolic pools and glycogen production. This accumulation of metabolites was concentrated before the phosphofructokinase step, suggesting a key role of this particular enzyme. Fig. 3 . Comparison of enzymatic levels in the CCM between the wild type and the csrA51 strains or at different growth rates. Enzymatic levels are issued from three independent replicates for the csrA51 strain and its isogenic wild type (mean 6 SD). The displayed values correspond to the log2 of the ratio of the csrA51 strain to its isogenic wild type (with propagation of uncertainty). Hatched columns represent log2 of ratio between enzymatic levels in the wild-type growing at l 5 0.3 (chemostatic cultures) to the same strain at l 5 0.6 (batch cultures). The asterisk represents significant ratio (P value <5% determined by t-test). The colour code matches the entity pathway (blue for the glycogen synthesis pathway, orange for the glycolysis pathway and gluconeogenesis pathways and green for the TCA cycle-related enzymes). 
Glycolytic activities are mainly under hierarchical control
Major reorganization of the CCM has been described above in the csrA51 mutant strain. CsrA is expected to regulate the levels of target enzymes and thus the corresponding fluxes. However, indirect control of fluxes by enzyme activities can also occur due to the important metabolome modifications observed in the csrA51 strain. Hierarchical regulation analysis (ter Kuile and Westerhoff, 2001; van Eunen et al., 2011) was therefore applied to the data to decipher the mode of flux control for glycolytic and glycogenic reactions (see Experimental procedures and supporting information S4 for details). Flux regulation was dissected into hierarchical regulation (q h ) and metabolic (q m ) coefficients, quantifying the contribution of changes in gene expression or metabolite pool to the flux change. The distributions of the resulting coefficients are displayed as boxplots in Fig. 5 . Median values of q h coefficients were close to 1 for most of glycolytic reactions (PYK, ENO, TPI and PGI) while higher values were obtained for glycogenic reactions (PGM and GLGC). All these q h coefficients are positive, indicating that in the csrA51 strain, changes in the catalyzing enzyme levels impose the flux changes. The metabolic regulations of these catalyzing enzymes, as indicated by the negative values of the q m , are antagonistic to the flux changes and therefore secondary in the control of the reaction. The result was different for the phosphofructokinase (PFK). The values of the regulation coefficients q h and q m coefficients were similar and equal to 0.5, revealing a shared control of the flux. This indicates that 50% of the PFK flux variation in the csrA51 strain could be attributed to metabolic changes within the cell and 50% to the modification of PfkA expression. Overall these results show that all the studied reactions are strongly affected at the level of their protein level by variations of the CsrA concentration. Only PFK appears to be controlled by CsrA through the combination of metabolic and hierarchical regulations.
Growth defect in the csrA51 mutant is limited to substrates requiring phosphofructokinase activity and associated to glucose phosphate stress
The csrA51 strain presents a reduced glucose uptake rate (Table 1) combined to the accumulation of metabolites before the phosphofructokinase step whose activity is under dual genetic and metabolic control (Figs. 3 and 4). To link these observations, we grew the WT and csrA51 strains on several glycolytic substrates entering the CCM Fig. 4 . Comparison of metabolite concentrations in the CCM between the wild-type and the csrA51 strains or at different growth rates.
Metabolic concentrations are issued from three independent replicates for the csrA51 strain and its isogenic wild type (mean 6 SD). The displayed values correspond to the log2 of the ratio of the csrA51 strain to its isogenic wild type (with propagation of uncertainty). Hatched columns represent log2 of ratio between metabolite concentrations in the wild-type growing at l 5 0.3 (chemostatic cultures) to the same strain at l 5 0.6 (batch cultures). The asterisk represents significant ratio (P value <5% determined by t-test). The colour code matches the entity pathway (blue for the glycogen synthesis pathway, orange for the glycolysis pathway and gluconeogenesis pathways, pink for the pentose phosphate pathway and green for TCA cycle-related metabolites). G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-biphosphate; 23PG, 3-phospho glycerate and 2-phospho glycerate; PEP, phosphoenolpyruvate; 6PG, 6-phospho glucono-1,5-lactone; R5P, ribose 5-phosphate and ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; cit, citrate; aKG, a-keto glutarate; Fum, fumarate; Mal, malate. before (glucose and N-acetylglucosamine) or after (fructose and fucose) the PfkA-mediated metabolic step (metabolic pathways summarized in Fig. 6A ). The csrA51 strain displayed a growth defect on both N-acetylglucosamine and glucose, whereas no measurable difference was observed during growth on fucose or fructose on the WT (Fig. 6B) . These results confirm that the growth defect of the csrA51 strain originated in the early steps of glucose metabolisation and emphasize the PfkA regulation as a crucial control. A controversial report pinpointed the accumulation of glycogen as the cause of the growth defect of a csrA mutant on glucose due to hijacking of the carbon flux towards this reserve sugar (Timmermans and Van Melderen, 2009 ). This disagrees with our results, which establish the phosphofructokinase metabolic step as the pivot of the growth defect. To clarify this point, csrA51 strains were grown on minimal media supplemented with either glucose, N-acetylglucosamine, fructose or fucose, and intracellular glycogen concentrations were quantified (Fig. 6B ). Independently of the substrate, the csrA51 cells accumulated much higher content of glycogen. Therefore, overaccumulation of glycogen in the csrA51 strain is independent of the type of glycolytic substrate and hence independent of the growth defect. This result goes against the hypothesis of glycogen accumulation as the cause of the growth defect, as previously objected (Revelles et al., 2013) . We conclude that glycogen accumulation is more likely a side effect of CsrA attenuation.
G6P and/or F6P over-accumulations as observed in the csrA51 mutant (Fig. 3) are known to trigger a feedback regulatory loop known as "glucose-phosphate stress" (Morita et al., 2003; Vanderpool, 2007) . The accumulation of these sugar phosphates indirectly induces the expression of the noncoding RNA SgrS (Vanderpool, 2007; Rice and Vanderpool, 2011) . SgrS triggers the degradation of the ptsG mRNA, encoding an essential component of the glucose transport system (Fig. 6A ). This results in a reduction of the glucose consumption rate, and hence, in a reduction of the sugar phosphate pools to counteract the stress. Since the pools of G6P and F6P were 2.5-3 times higher in the csrA51 strain compared to WT and since the ptsG level was reduced ( Figs. 2 and 4) , we looked for molecular evidence of glucose-phosphate stress by investigating the level of expression of SgrS in both strains grown on glucose, N-acetylglucosamine, fructose and fucose. SgrS transcript levels were 5-7 times higher in the csrA51 grown on glucose and N-acetylglucosamine respectively (Fig.  6B ). Such induction was not found in the two strains grown on fructose or fucose. These results are evidence for the existence of a glucose phosphate stress coupled with a growth defect for the csrA51 strain grown on substrates that require phosphofructokinase activity. In conclusion, csrA51 growth defect is not associated to a glycogen accumulation but to a glucose-phosphate stress when the mutant is grown on substrate entering the glycolytic pathway above the phosphofructokinase step.
Overexpression of PfkA suppresses the hexose phosphate stress and partially restores the growth rate of the csrA51 mutant A deletion of pfkA has been reported to present a strong growth defect on glucose medium with a growth rate Impact of the CSR system on upper glycolysis 7 V C 2016 John Wiley & Sons Ltd, Molecular Microbiology, 00, 00-00 close to 0.1 h 21 (Fischer and Sauer, 2003; Nakahigashi et al., 2009) . We therefore hypothesized that the limited PfkA activity inherent to the csrA51 strain could be sufficient to explain the growth defect directly by blocking the glycolytic pathway, or indirectly through the feedback loop of the glucose phosphate stress. We assessed this by overexpressing the pfkA gene in the WT and csrA51 strains and growing them on M9 glucose (Fig. 7) . Measurements of pfkA mRNA levels and of PFK enzymatic activities showed that the overexpression enabled pfkA expression and phosphofructokinase activity to be restored in the csrA51 strain ( Fig. 7A and B) . We then investigated the effect of pfkA overexpression on G6P metabolic pool and on SgrS accumulation. While csrA51 increased the G6P pool, the overexpression of pfkA abolished the phenomenon (Fig. 7C ). As expected from the moderate G6P pool, the SgrS induction in the csrA51 mutant is prevented by pfkA overexpression (Fig. 7D) . The overexpression did not prevent glycogen accumulation (Fig. 7E ). Finally, overexpression of pfkA moderately but significantly increased the growth rate in the csrA51 strain ( Fig. 7F ). Taking as a whole, these results comfort PfkA as a most important target of the CSR system in the central carbon metabolism.
Discussion
The present work reveals the major role of posttranscriptional regulation in the control of the central carbon metabolism of E. coli. The multilevel analysis and data integration demonstrated the strong control of the CSR post-transcriptional regulatory system in the upper part of the glycolysis. Attenuation of CsrA activity results in a decrease in most glycolytic activities, especially the phosphofructokinase. This was shown to provoke an accumulation of metabolites in the top of glycolysis before the phosphofructokinase step and hence a glucose-phosphate stress controlling negatively the sugar uptake. Consequences of this cascade of regulations A. Simplified representation of the metabolic pathways and point of entry in the CCM for four glycolytic substrates. B. Growth rates, glycogen contents and SgrS level of expression for the wild-type and the csrA51 strains on a variety of glycolytic substrates. Each growth rate, glycogen content and SgrS levels is issued from the mean 6 SD of three independent biological replicates. The ratio r 5 csrA51/WT is given for each substrate.
are dramatic for the cell growth rate, and we propose this explains the essentiality of the CSR system on glucose.
Influence of the CSR system over the CCM has already been reported in the literature. However, the information was limited to one level of observation [for example, activities in Sabnis et al. (1995) Revelles et al. (2013) ]. The strength of the present work is to provide the first coherent investigation of the CSR influence on the CCM through the measurement of growth properties, enzyme activities, metabolite pools and fluxes of the model bacterium E. coli MG1655. It confirms that the CSR system controls several pathways of the CCM (glycogenesis, glycolysis, gluconeogenesis, TCA cycle and acetate metabolism). The multilevel investigation also allowed demonstrating that the control is largely exerted at the gene expression level with repercussions on enzyme activities and fluxes distribution. Some previously identified targets like Fbp or Pck were shown to result from the growth rate modification triggered by the CsrA mutation during glucose consumption. This permitted to refine the list of CSR targets in the CCM to the upper glycolysis and glycogenesis and this finding was corroborated by the accumulation of metabolites in this pathway for the csrA51 mutant. Very interestingly, all the five glycolytic steps studied in this work (PGI, PFK, TPI, PYK and ENO) displayed a coherent decrease in their gene expressions, of enzyme abundances, and flux ratios in the csrA51 strain. This was corroborated by the predominant hierarchical control of their glycolytic fluxes. Thus, these results strongly suggest that glycolytic enzymes are under direct and coordinated regulation by CsrA.
CsrA has been reported to be essential for E. coli growth on glycolytic substrates because it over- Fig. 7 . Overproduction of pfkA in the wild-type and csrA51 strains. Wild-type or csrA51 strains were transformed by the empty vector or the vector carrying the pfkA gene ("pfkA1"). A. pfkA mRNA levels in the four strains. B. PfkA-specific activities in the four strains. C. G6P concentration in the four strains. D. SgrS ncRNA levels in the four strains. E. Glycogen content in the four strains. F. Growth rates of the four strains. Each value is issued from the mean 6 SD of three independent biological replicates. The asterisk represents significant differences between the strain overexpressing pfkA and its control (P value <85% determined by t-test).
accumulates glycogen (Timmermans and Van Melderen, 2009) . We show here that attenuation of the essential CsrA post-transcriptional regulator creates a growth defect in presence of glucose in rich or minimal medium. The accumulation of glycogen was observed in the csrA51 strain, independently of the growth rate default. This suggests that glycogen accumulation is not the actual cause of the CsrA essentiality. The growth defect was not observed with all glycolytic substrates (i.e., not on fructose or fucose) and was related to the upper part of glycolysis. Using systematic analysis of CCM components in the wild-type and csrA51 strains, we discovered that most of the molecular discrepancies between the two strains are indeed located in the close vicinity of the point of glucose entry into the central carbon metabolism. The most down-regulated enzyme of the glycolytic pathway was PfkA. Since substrates entering the CCM after this metabolic step are not associated with a csrA51 growth defect, we hypothesized that down-regulation of PfkA creates an engorgement of the metabolic fluxes in the first glycolytic reaction that could lead to the growth deficiency. This hypothesis was supported by the observed higher pools of F6P and S7P [i.e., the two PfkA substrates (Nakahigashi et al., 2009) ] and more largely by the accumulation of metabolites in the top of glycolysis before the PfkA step. Restoring a wild-type level of PfkA in the csrA51 mutant prevent these metabolite accumulation and partially restore the growth rate. From all these elements, we conclude that PfkA plays a major role in the csrA51 phenotypes. However, all the consequences of the csrA51 mutation on the CCM cannot be mediated through PfkA down regulation only. First, the pfkA deletion does not entirely prevent growth on glucose minimal medium as observed in a strain in which csrA is deleted (Nakahigashi et al., 2009; Timmermans and Van Melderen, 2010) . Second, restoring the WT level of PfkA expression did not entirely restore a WT growth rate in the csrA51 strain (this work). Glycolytic flux control is known to be shared among its enzymes in microorganisms (Smallbone et al., 2013) . This might explain why the influence of the CSR system is so dramatic since it controls the expression of most of the glycolytic enzymes conjointly, among which PFK appears to be the most crucial metabolic step.
An important metabolic consequence of the reduced glycolytic fluxes is the accumulation of sugar phosphates G6P and F6P. F6P and S7P were reported to accumulate in the csrA51 mutant of the Nissle 1917 background, but not G6P. We demonstrated here that the accumulation of hexose phosphate triggers glucose phosphate stress as a feedback control in the csrA51 strain through the expression of its characteristic marker SgrS (Vanderpool, 2007; Rice and Vanderpool, 2011) .
SgrS is known to reduce glucose transport by facilitating the degradation of the ptsG messenger. This was confirmed by our multilevel analyses, which revealed reduced ptsG expression in the csrA51 strain. Overexpression of pfkA in the csrA51 strain suppressed the glucose-phosphate stress and partially restored the growth. Thus, CsrA attenuation results in a subefficient glycolysis unable to absorb the G6P pool which trigger SgrS and reduced glucose entrance in the cell. On the basis of our results, we proposed that csrA essentiality is due to its essential role to promote glycolysis. This suggests that the primary function of the CSR system in the CCM is to adjust the glycolytic activity to the carbon availability and cellular requirement. CSR was previously proposed to fine tune the stringent response (Edwards et al., 2011) , which is also related to the growth rate response. This reinforces that one function of the CSR system is to coordinate the fine tuning of the glycolytic activities and the growth rate.
Post-transcriptional regulation of central carbon metabolism has been almost ignored so far, but it now appears to play a crucial role in its correct tuning. One drawback in biotechnology approaches is the robustness of the CCM system (Sauer et al., 1999) . It was recently shown that csrB overexpression is of interest for biotechnologies since it produces low levels of fermentation products (McKee et al., 2012) . Here, we demonstrate the high potential of CSR mutants in biotechnologies since they allow reshaping of the CCM metabolic pools and fluxes. These new organizations offer many opportunities such as exploiting the larger pools of sugar phosphates to ensure the production of high added value compounds.
Experimental procedures

Strains
The strains used in this study were the wild-type strains E. coli K12-MG1655 and the previously constructed and validated csrA51 strain corresponding to a partial deletion of the 10 last amino acids of the CsrA protein by using k red system recombination (Esquerr e et al., submitted). pfkA overexpression in the wild type or the csrA51 background was achieved by cloning a 1963 pb fragment including pfkA and its promoter into the Kpn1-HindIII sites of a pUC19 plasmid. The fragment was amplified from the MG1655 genome (5 0 Primer: ATTGAGGTACCGATGAGGAACG-GAAGGAAGAAATTATTG and 3 0 Primer: TAACTAAGCTTG AATCACCACGTTATCACCAGTTT).
Media and growth conditions
Bioreactor cultures were performed in 500 ml of M9 medium complemented with 2.7 g Á l 21 of D-glucose. The cultures were inoculated at an optical density of 0.2 after overnight preculture of the wild-type strain and a 48 h preculture of the csrA51 strain. At least three independent replicates were made for each strain in the same conditions (stirring at 800 r.p.m., pH 7, 378C and air flow at 0.2 l Á s 21 ). These parameters were set and monitored using a Multifors bioreactor system (Infors, Switzerland). The percentages of CO 2 and O 2 in the gas output were determined using a Dycor ProLine Process Mass Spectrometer (Ametek, DE, USA). During the cultures, OD and extracellular metabolites were measured every 30 min. Several samples were taken for enzymatic assays, intracellular metabolites analysis and qPCR experimentations during the midexponential phase of the culture (OD 5 1.5) for each biological replicate. Growth in chemostat was performed in M9 glucose using a 0.5 l Sartorius bioreactor controlled by a Biostat Qplus device as described in Esquerre et al. (2014) . Cultures in LB or on the range of substrates as well as for pfkA overexpression were performed in a baffled shake flask at 378C in 50 ml of M9 glucose complemented with either 2.7 g Á l 21 D-glucose, 2.7 g Á l 21 D-fructose, 2.45 g Á l 21 L-fucose, or 2.5 g Á l 21 N-acetyl-(D)-glucosamine.
Calculation of fermentation parameters
For all the cultures, different growth parameters were calculated during the exponential phase of growths. All these parameters remained constant during this growth phase. The maximum growth rate in h 21 was calculated by determining the mean of all the instant growth rates acquired during the exponential phase using the following equation where X is the biomass concentration in gDW Á l 21 :
The maximum glucose uptake rate (mmol GLU Á h 21 Á gDW 21 ) was calculated by determining the mean of all the instant glucose uptake rates acquired during the exponential phase using the following equation:
Acetate yield was calculated by determining the mean of all the instant acetate yields acquired during the exponential phase using the following equation:
CO 2 production rate (mmol CO2 Á h 21 Á gDW 21 ) was calculated by determining the mean of all the instant CO 2 production rates acquired during the exponential phase using the following equations set:
Q OUT is the air outflows (g air Á h 21 ), Q IN is the air inflows (g air Á h 21 ), Fm CO2 is the molar fraction of CO 2 in the air, M CO2 corresponds to the CO 2 molar mass, Vm CO2 is the CO 2 molar volume and Vf the medium volume.
Enzymatic assays
The equivalent of 40 mg of dried cells was sampled during bioreactor cultures to perform enzymatic assays. The cells were pelleted (10 min at 6000 r.p.m. at 48C) before being washed twice with 0.2% KCl (v/v) and resuspended in 2 ml of a Tris-carballylic acid breaking buffer (Tris-tricarballylate pH 7.8, 2.7 M glycerol, 50 mM MgCl 2 , 300 mM DTT). The cells were then mechanically broken by six beating cycles of 30 s each separated by 1 min on ice using a Mini-Beadbeater2 (Biospec Products, Bartlesville, OK, USA) and Sigma glass beads (0.6 g of glass beads for 1 ml of cells). The cell extract was isolated after centrifugation (13,200 r.p.m. at 48C for 15 min) and used in the following hours for enzymatic assays. Eleven enzymatic activities were obtained by measuring the changes in NADH or NADPH concentration at 340 nm using the SPECTRAmax PLUS 384 microplate reader (Molecular Devices, Sunnyvale, CA, USA). All the reagents used were purchased from Sigma-Aldrich (USA). The optical density was measured at 7 s intervals for 10 min with a 3 s shaking phase between readings. The assays were performed in a total volume of 200 ml (including 10, 20 or 40 ml of extract) at 378C, and the reactions were started by adding the substrate. Enzyme activities were determined from the linear part of the reaction. The total protein concentration in each extract was quantified by Bradford assay (Bio-Rad Protein assay, Bio-Rad, Germany) at 595 nm to obtain specific activities (mmol Á g 21 prot Á h 21 ) (Bradford, 1976) . Phosphoglucoisomerase (Pgi) was assayed in the nonphysiologic direction using Tris-HCl buffer (0.1 M, pH 7.8), MgCl 2 (5 mM), NADP (5 mM), glucose 6-phosphate-1dehydrogenase (0.2 U) and fructose 6-phosphate (10 mM). Phosphofructokinase (Pfk), triosephosphate isomerase (Tpi) and enolase (Eno) assays were performed as described in Even et al. (2001) . Pyruvate kinase (Pyk) was measured using a modified method derived from Even et al. (2001) : fructose 1,6-diphosphate (3 mM) was added to the assay and GDP (30 mM) was replaced by ADP (30 mM). Acetyl-coenzyme A synthetase (Acs) was assayed as developed by Castano-Cerezo et al. (2009) ; the isocitrate lyase (AceA) assay was performed as described in Van der Werf et al. (1997) . We also followed this author's protocol for the phosphoenolpyruvate carboxykinase assay (PckA) but in a Tris-HCl buffer (0.1 M, pH 7.8). The fructose bisphosphatase (Fbp) assay was adapted from Peng and Shimizu (2003) by replacing the buffer with a Tris-HCl buffer (50 mM, pH 7.8). The phosphoglucomutase (Pgm) assay was that of (Joshi, 1982) using 40 mM of the same Tris-HCl buffer. Glucose 1-phosphate adenyltransferase (GlgC) was measured using phosphate buffer (100 mM, pH Impact of the CSR system on upper glycolysis 11 V C 2016 John Wiley & Sons Ltd, Molecular Microbiology, 00, 00-00 7.8), MgSO 4 (5 mM), NADP (0.5 mM), fructose 1,6-diphosphate (10 mM), glucose 6-phosphate1-dehydrogenase (0.2 U), phosphoglucomutase (1 U) and ADP-glucose (8 mM). Malate synthase (AceB) was assayed in Tris-HCl buffer (0.1 M, pH 7.8), MgSO 4 (5 mM), acetyl-CoA (4 mM), NAD (3 mM), malate dehydrogenase (4 U) and glyoxylate (4 mM).
Extracellular and intracellular metabolites
The extracellular metabolites were identified and quantified using H1 HPLC (Agilent Technologies 1200 Series HPLC and Aminex HPX-87H column for acid and sugar separation). The analysis was carried out at 488C using H 2 SO 4 5 mM as eluent.
Intracellular metabolites were sampled at the midexponential phase using the differential method of Taymaz-Nikerel et al. (2009) : 120 ml of broth or filtered culture (Sartolon polyamide 0.2 mm, Sartorius, Goettingen, Germany) were mixed with 1.25 ml of a quenching solution composed of 40% methanol, 40% acetonitrile and 20% water in a hemolysis tube. The tubes were stored at 2208C until analysis. A total of 120 ml of a fully 13 Clabeled cell extract were added to each tube as internal standard before the extracts were evaporated for 5 h in a SC110A SpeedVac Plus (ThermoFischer, MA, USA). The pellet was then resuspended in 120 ml of ultrapure water. Intracellular metabolites were quantified by highperformance anion exchange chromatography (Dionex ICS 2000 system, CA, USA) coupled to a triple quadrupole QTrap 4000 mass spectrometer (AB Sciex, CA, USA). The signals were processed and quantified using Analyst software (Analyst Software, AB SCIEX, USA).
RT-PCR analysis
Gene expression levels were analysed using Q-PCR in micro-Fluidigm or classical RT-PCR. At the midexponential phase, the equivalent of 5 mg of cells (dry weight) was harvested and directly flash-frozen in liquid nitrogen. RNA extraction was performed according to the TRIZOL method for E. coli described in Esquerr e et al.
(2014) and the concentration of RNA was determined using a NanodropV R spectrophotometer. After a quality control by capillary electrophoresis (Bioanalyzer from Agilent, Santa Clara, CA, USA), the samples were subjected to reverse transcription using the Superscript II Reverse transcriptase (Life Technology). The Q-PCR EvaGreen experiment (Mao et al., 2007) was performed on a Biomark 96.96 dynamic array (Fluidigm, San Francisco, CA, USA). Ninety samples were tested against 33 pairs of designed primers (Table 2) in technical triplicate. An internal control of human DNA was used to check the efficiency and quality of the run. Briefly, the experiment was carried out in three steps. First, in each cDNA sample, targeted cDNA was amplified using the pool of primers and TaqManV R PreAmp Master Mix (Fluidigm, San Francisco, CA, USA) with the following program: (i) 10 min at 958C, (ii) 14 cycles of 15 s at 958C and 4 min at 608C. The samples were then treated with exonuclease ExoI (for 30 min at 378C for digestion and for 15 min at 808C for inactivation). Finally, the samples were added to a premix (2X TaqMan Gene Expression Master Mix, 20X DNA Binding Dye Sample Loading Reagent, 20X EvaGreenV R and TE buffer) before being loaded into the macroarray. The sets of primers were loaded into the macroarray at a concentration of 20 mM. Control idnT values were used to normalize the data. 
Name
Sequence
A classic RT-PCR was also used to study the SgrS expression level and to check for pfkA overexpression using the SYBR Green-based detection protocol (Life Technology), an ICycler real-time PCR detection system (Biorad) and "MyIQ" software (Biorad), as described in Enjalbert et al. (2013) .
Glycogen staining assays and intracellular glycogen quantification
Strains were grown overnight at 378C in 50 ml M9 media containing either 2.7 g Á l 21 D-glucose, 2.7 g Á l 21 D-fructose, 2.45 g Á l 21 L-fucose or 2.5 g Á l 21 N-acetyl-(D)-glucosamine. The intracellular glycogen content of both csrA51 and the wild-type strains was quantified at midexponential growth. The experiments were performed in biological and technical duplicate. The quantification was done as described in Parrou and François (1997) . Briefly, the cells were lysed to extract the glycogen which was then hydrolysed by amyloglucosidase into glucose subunits. The glucose subunits were then quantified using a glucose oxidase coupled to the colorimetric reagent odianisidine dihydrochloride.
Metabolic flux analysis
A slightly modified version of the genome-scale reconstruction iAF1260-flux2 of E. coli was used for all simulations (Feist et al., 2007) . These were performed using the COBRAv2 Toolbox with Gurobi 6.0.4 as linear programming solver (Schellenberger et al., 2011) . The model and the definition of its maintenance fluxes and constraints are described in supporting information S2 and S3. In order to determine the intracellular distribution of fluxes consistent with the measured exchange fluxes and growth rate, we performed a metabolic flux analysis, where the objective was to minimize the measured and predicted exchange fluxes and growth rate. Let v denotes the vector of steadystate fluxes with lower bounds v l and upper bounds v u , N the stoichiometric matrix, u 1 and u 2 non-negative dummy fluxes, and u M the vector of p measurements of exchange fluxes and growth rate. We assume that the first p elements of v correspond to the measured fluxes. Similarly to what was done in Lee et al. (2012) , the metabolic flux analysis can be then formulated as the following linear programming problem: min P p j51 ðu 1 j 1 u 2 j Þ subject to:
Nv 50; v l v v u ; v j 2u 1 j 1 u 2 j 5 u M j ; for all j51; . . . ; p; u 1 ; u 2 ! 0:
Using this objective function, metabolic flux analysis was performed for the wild-type and csrA51 strains, followed by a flux variability analysis (Mahadevan and Schilling, 2003) to analyse the space of solutions. This allowed us to obtain lower and upper bounds for reaction fluxes in the two strains that are consistent with the measured growth rate and exchange fluxes.
Hierarchical regulation analysis
Regulation analysis dissects flux regulation into a hierarchical regulation coefficient q h and a metabolic coefficient q m (van Eunen et al., 2011) . In this study, q h quantifies to which extent changes of protein levels in the csrA51 strain, resulting in the modification of enzyme-specific activities (SA), contribute to the change of flux (v ):
The coefficient q m quantifies the effect of changes in the interaction of the enzyme with the rest of metabolism on the change of flux, through variations in the concentration of substrates, products and allosteric effectors. The coefficient q h is directly determined from the data and the fluxes using Eq. (1), while the coefficient q m is derived from the following summation theorem:
The regulation coefficients for each reaction were calculated from Eqs. (1) and (2) and combinations of the different replicates of enzyme-specific activities and the minimal and maximal flux values returned by the metabolic flux analysis (see supporting information S4 for details). The statistical distribution of the regulation coefficients for each reaction was represented by means of box plots. Wilcoxon signed-rank tests enabled us to statistically assess the type of regulation exerted by the metabolism and gene expression (see supporting information S4 for details).
